Researchers have identified a handful of molecules circulating in the bloodstream that can signal a person’s risk of ...

The majority of patients with type 2 diabetes (T2D) have less than ideal metabolic control despite our greater understanding of the underlying pathophysiologic mechanisms of hyperglycemia and the ...

Health-related quality of life (HRQoL) in type 2 diabetes encompasses the physical, psychological and social dimensions of well-being as experienced by individuals living with the condition. Beyond ...

Type 2 diabetes represents a growing global health burden, with early detection and risk stratification pivotal to reducing complications and healthcare costs. Screening programmes employ a range of ...

Palmitic acid, the most abundant saturated fat in processed foods and red meat, tracks with higher type 2 diabetes risk ...

No, having prediabetes is not a guarantee that you will develop type 2 diabetes. You can lower your chance of a diabetes diagnosis with lifestyle changes, such as eating choices, exercise routines, ...

You can develop high blood sugar (hyperglycemia) with type 2 diabetes. This may mean you need to work with your doctor to update your diabetes care plan, consider insulin, or adjust your medications.

Medicines called glucagon-like peptide-1 (GLP-1) receptor agonists have changed how type 2 diabetes is treated. GLP-1 medicines, like semaglutide (Rybelsus), work by acting like the body’s natural GLP ...

Many patients with type 2 diabetes wonder how their blood sugar levels can be high when they have not eaten anything. The ...

The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associated with type 2 diabetes.

The best time for someone with type 2 diabetes to check their blood sugar depends on whether or not they are using insulin. People should speak with their healthcare team to learn when they should ...

Biomea Fusion presented positive data on icovamenib for type 2 diabetes, showing improved glycemic control and weight loss in clinical trials. Biomea Fusion announced promising new data for icovamenib ...